Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Trichomonas vaginalis</i> PPi-dependent phosphofructokinase structures reveal a non-canonical nucleotide binding site.

bioRxiv : the preprint server for biology·2026

Same author

Dual-Mode Native Mass Spectrometry Screening Identifies Ginsenoside Ligands of 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase (HPPK).

Molecules (Basel, Switzerland)·2026

Same author

Assessing Metal Ion Assignment Accuracy in Protein Data Bank Models via Elemental Spectroscopy.

Journal of chemical information and modeling·2026

Same author

Crystal structure of Plasmodium vivax macrophage migration inhibitory factor.

Acta crystallographica. Section F, Structural biology communications·2026

Same author

Automated extraction and optimization of protein purification protocols using multi-agent large language models.

bioRxiv : the preprint server for biology·2026

Same author

Structural and Functional Analyses of <i>Trypanosoma brucei</i> Nucleoside Diphosphate Kinase.

ACS omega·2026

Search research articles

Related Experiment Video

Updated: May 15, 2026

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

Published on: July 1, 2018

A new drug for an old bug.

Peter J Myler, Robin Stacy

Chemistry & Biology

|December 25, 2012

Summary

Researchers developed new drugs targeting malate synthase, essential for Mycobacterium tuberculosis survival during chronic infection. This structure-guided approach offers a promising strategy against persistent tuberculosis.

Area of Science:

Biochemistry
Drug Discovery
Microbiology

Background:

Tuberculosis (TB) remains a significant global health challenge, necessitating novel therapeutic strategies, especially for latent and persistent forms.
Mycobacterium tuberculosis (Mtb) utilizes the glyoxylate shunt for survival during chronic infection.
Malate synthase is a key enzyme in the Mtb glyoxylate shunt, making it a potential drug target.

Discussion:

Krieger and colleagues employed a structure-guided approach to design and synthesize novel inhibitors of malate synthase.
These inhibitors specifically target a critical enzyme for Mtb survival in host macrophages.
The study highlights the potential of targeting the glyoxylate shunt for anti-TB drug development.

Key Insights:

Identification of novel malate synthase inhibitors with potential anti-TB activity.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 15, 2026

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

Published on: July 1, 2018

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Demonstration of a structure-guided drug design strategy for targeting Mtb.

Validation of malate synthase as a viable target for combating persistent tuberculosis.

Outlook:

Further preclinical development of these malate synthase inhibitors is warranted.
This approach could be extended to discover inhibitors for other essential Mtb enzymes.
The findings contribute to the urgent need for new drugs against drug-resistant and persistent tuberculosis strains.